Open | $120.420 |
Close | $123.410 |
Volume / Avg. | 841.678K / 608.412K |
Day Range | 120.420 - 123.929 |
52 Wk Range | 111.251 - 147.980 |
Market Cap | $7.694B |
P/E Ratio | 20.231 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 4.3% |
Days to Cover | 5.94 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.
Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), CymaBay Therapeutics (NASDAQ:CBAY) and Novartis (NYSE:NVS).
The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Stifel on Friday, March 15, 2024. The analyst firm set a price target for 230.00 expecting JAZZ to rise to within 12 months (a possible 86.37% upside). 30 analyst firms have reported ratings in the last year.
The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $123.41 last updated March 18, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Jazz Pharmaceuticals.
Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Jazz Pharmaceuticals.
Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.